News

Jun 16,2021

KBP Biosciences Announces A Greater Than 10 mm Hg Systolic Blood Pressure Reduction in The BLOCK-CKD Phase 2b Study of KBP-5074 in Advanced Chronic Kidney Disease Patients with Uncontrolled Hypertension as Published in Hypertension

Jun 07,2021

Cytek Biosciences Introduces a New High-Dimensional Sorter

May 21,2021

Cardea Bio Partners with Scentian Bio to Power Insect Odorant Receptor-Enabled Flavor Profiling Product

May 18,2021

MD Anderson and Refuge Biotechnologies Collaborate to Advance Next-Generation Cell Therapies for Treatment of Solid Tumors

May 08,2021

Twist Bioscience Reports Second Quarter Fiscal 2021 Financial Results

May 04,2021

Cardea Bio Develops Exosome and Extracellular Vesicles (EV) Detection Technology Called EV-Chip, Showcasing Cancer and Aging Dx Applications

Apr 28,2021

Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer

Mar 30,2021

Immune-Onc Therapeutics Announces $73 Million in Series B1 and B2 Financing to Advance its Portfolio of Novel Immunotherapies in Blood Cancers and Solid Tumors

No more pages to load

Next page